Trillium Therapeutics Announces Proposed Public Offering of Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/25/2026
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Oil drops more than $2 despite new US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- Grand Canyon Education places CFO on leave amid stock trade probe
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Funds sell $44bn in semiconductors on AI concerns
- RUM Group signs $13.7 billion GPU services deal, issues warrants
UPDATE: Trillium Therapeutics (TRIL) Prices 1.52M Common Offering at $19.50/Share
April 1, 2015 7:01 AM EDT(Updated - April 1, 2015 7:03 AM EDT)
Trillium Therapeutics (NASDAQ: TRIL) has priced a 1.52 million common stock offering at $19.50 per share.
UPDATE - The press release and SEC filing follow:
Trillium Therapeutics announced that it has priced an underwritten public offering of 1,522,395 common... More
Trillium Therapeutics (TRIL) Announces $50M Common Stock Offering
March 30, 2015 4:03 PM EDTTrillium Therapeutics (NASDAQ: TRIL) announced that it is offering to sell US$50,000,000 of common shares and preferred shares in an underwritten public offering. The preferred shares are being offered to certain of Trillium's existing shareholders whose purchase of common shares in this offering may... More
